Navigation Links
Reducing The Frequency Of Angina Attacks While Exercising

Researchers say a new treatment can now help chronic chest pain sufferers exercise longer. When the drug ranolazine was taken // with other antianginal medications it was found to improve the total exercise time of patients with symptoms of chronic angina.

Ranolazine is currently under review by the FDA. For this study, more than 800 patients with symptomatic chronic angina were randomly assigned to receive a placebo or one or two doses of ranolazine. Patients received either placebos twice a day or 750 mg or 1000 mg of ranolazine. Then, they were monitored as they exercised on a treadmill 12 hours after receiving the medication (when it was at the lowest levels in the bloodstream) and four hours after receiving it (when there were the highest levels of the drug in the bloodstream).

Researchers found that when added to a standard dose of frequently prescribed antianginal drugs, ranolazine can reduce both the angina frequency and nitroglycerin consumption. When compared to the placebo results, the decrease in angina attacks were slightly less than one per week for those in the 750 mg group and somewhat more than one per week in the 1,000 mg group. They also found exercise duration increased by nearly two minutes for those in the ranolazine therapy group compared with 90 seconds for those taking placebos. Specialists say, the availability of another effective and apparently safe antianginal medication is “particularly important” for angina patients who are not candidates for revascularization.
'"/>




Page: 1

Related medicine news :

1. Reducing Lung Cancer Risk
2. Reducing the risk for type 2 diabetes
3. Reducing Medication Errors
4. Reducing HIV Transmission
5. Reducing Pain from Knee Surgery
6. Reducing Pain From Knee Surgery
7. Reducing The After Effects of Tonsillectomy
8. Antiparasitic Drug Effective In Reducing Seizures In Neurocysticercosis Patients
9. Reducing Number Of Cigarettes Not Enough
10. Drug Found Effective In Reducing Vertebral Fractures In Women
11. Reducing TB With Ultraviolet Light
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... ... ... manicurist from Greet, S.C., wants to offer people a new way to care for their ... feet, so I know the importance of proper foot care," he said. "In order to ... , The FOOT-TRAN SYSTEM enables a user to clean and exfoliate the bottoms of his ...
(Date:3/30/2017)... ... March 30, 2017 , ... This morning, more than 275 ... their support for an independent Vaccine Safety Commission. Five of the signers of ... will hold a press conference at 9:00 AM Friday, March 31 at ...
(Date:3/29/2017)... ... ... In the United States alone, up to 36% of primary brain tumors ... brain tumors(3). Though most meningiomas are benign, metastatic brain tumors are known to grow ... options, the San Diego Gamma Knife Center offers a precision-medicine based solution ...
(Date:3/29/2017)... ... ... Grass pollen is the main cause of hay fever in the United States, with an ... runs from May to July each year; with the worst time for sufferers being June ... balms ( http://www.haymax.us ) provide an effective defense against grass pollen; they are proven in ...
(Date:3/29/2017)... ... 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, are big fans ... been used for thousands of years. , "The West has caught on, and has ... How to Use it For Your Wellness. Overcome Inflammation, Enemy of the Body. " ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... HUNTINGTON BEACH, Calif. , March 29, 2017 ... treatment have recognized remote monitoring devices like  Soberlink ... monitoring.   The consensus paper, published in early ... "feasible, practical and valuable in managing patient recovery." ... published in the Journal of Addiction Medicine, detail ...
(Date:3/29/2017)... leader in accelerated orthodontics, OrthoAccel ® Technologies, Inc. ... Manal Ibrahim , Kenji Ojima , Ivan ... microlecture presenters at the AcceleDent ® booth (#3037) ... Session, April 21-25, 2017. Orthodontists and their staff are ... a.m. On the opening morning of AAO exhibitions, Sat., ...
(Date:3/29/2017)... N.J. , March 29, 2017  Glenmark ... results for GSP 301, an investigational fixed-dose combination ... (665 mcg) administered twice-daily as a nasal spray ... rhinitis. These results are from a recently completed ... of GSP 301 combination therapy versus mometasone, olopatadine ...
Breaking Medicine Technology: